Allarity Therapeutics (ALLR) Competitors $1.25 +0.06 (+4.62%) (As of 02:59 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends ALLR vs. ABVC, EVOK, EDSA, RNAZ, ADIL, EYEN, XBIO, VCNX, AIMD, and VIRXShould you be buying Allarity Therapeutics stock or one of its competitors? The main competitors of Allarity Therapeutics include ABVC BioPharma (ABVC), Evoke Pharma (EVOK), Edesa Biotech (EDSA), TransCode Therapeutics (RNAZ), Adial Pharmaceuticals (ADIL), Eyenovia (EYEN), Xenetic Biosciences (XBIO), Vaccinex (VCNX), Ainos (AIMD), and Viracta Therapeutics (VIRX). These companies are all part of the "pharmaceutical preparations" industry. Allarity Therapeutics vs. ABVC BioPharma Evoke Pharma Edesa Biotech TransCode Therapeutics Adial Pharmaceuticals Eyenovia Xenetic Biosciences Vaccinex Ainos Viracta Therapeutics ABVC BioPharma (NASDAQ:ABVC) and Allarity Therapeutics (NASDAQ:ALLR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, media sentiment, earnings, risk, community ranking and dividends. Does the MarketBeat Community believe in ABVC or ALLR? Allarity Therapeutics received 1 more outperform votes than ABVC BioPharma when rated by MarketBeat users. CompanyUnderperformOutperformABVC BioPharmaN/AN/AAllarity TherapeuticsOutperform Votes150.00% Underperform Votes150.00% Which has higher earnings and valuation, ABVC or ALLR? ABVC BioPharma has higher revenue and earnings than Allarity Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioABVC BioPharma$150K45.86-$10.52M-$0.86-0.62Allarity TherapeuticsN/AN/A-$11.90MN/AN/A Do institutionals & insiders have more ownership in ABVC or ALLR? 11.4% of ABVC BioPharma shares are owned by institutional investors. Comparatively, 11.5% of Allarity Therapeutics shares are owned by institutional investors. 11.9% of ABVC BioPharma shares are owned by insiders. Comparatively, 0.1% of Allarity Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more risk and volatility, ABVC or ALLR? ABVC BioPharma has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500. Comparatively, Allarity Therapeutics has a beta of 0.3, indicating that its share price is 70% less volatile than the S&P 500. Is ABVC or ALLR more profitable? Allarity Therapeutics has a net margin of 0.00% compared to ABVC BioPharma's net margin of -1,619.65%. ABVC BioPharma's return on equity of -104.94% beat Allarity Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets ABVC BioPharma-1,619.65% -104.94% -56.81% Allarity Therapeutics N/A -369.67%-100.06% Does the media prefer ABVC or ALLR? In the previous week, Allarity Therapeutics had 4 more articles in the media than ABVC BioPharma. MarketBeat recorded 5 mentions for Allarity Therapeutics and 1 mentions for ABVC BioPharma. Allarity Therapeutics' average media sentiment score of 0.81 beat ABVC BioPharma's score of 0.73 indicating that Allarity Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ABVC BioPharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Allarity Therapeutics 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryABVC BioPharma beats Allarity Therapeutics on 6 of the 11 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get Allarity Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ALLR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALLR vs. The Competition Export to ExcelMetricAllarity TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.76M$6.53B$5.10B$8.84BDividend YieldN/A8.11%5.04%4.07%P/E RatioN/A5.5695.6214.26Price / SalesN/A371.591,217.1987.73Price / CashN/A52.5939.5936.27Price / Book0.1410.236.946.36Net Income-$11.90M$153.22M$118.89M$225.56M7 Day Performance-11.70%-1.36%-1.33%-0.10%1 Month Performance-23.62%-6.81%-3.17%2.02%1 Year Performance-99.59%32.27%32.49%27.87% Allarity Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALLRAllarity Therapeutics0.7633 of 5 stars$1.25+4.6%N/A-99.6%$1.76MN/A0.005Gap UpABVCABVC BioPharma0.751 of 5 stars$0.53-6.6%N/A-66.4%$6.88M$150,000.00-0.6630Gap UpEVOKEvoke Pharma0.0508 of 5 stars$4.59+0.7%N/A-69.5%$6.84M$5.18M-0.414Analyst ForecastEDSAEdesa Biotech3.1653 of 5 stars$2.06-6.4%$21.00+919.4%-27.9%$6.70MN/A0.0020Gap DownRNAZTransCode Therapeutics2.6592 of 5 stars$0.38+12.9%$3.00+690.1%-96.3%$6.56MN/A0.009ADILAdial Pharmaceuticals2.5225 of 5 stars$1.00-2.0%$8.00+700.0%-50.5%$6.41MN/A0.0020EYENEyenovia2.845 of 5 stars$0.10+8.2%$2.00+1,900.0%-93.2%$6.41MN/A0.0040Analyst DowngradeShort Interest ↓Analyst RevisionNews CoverageGap DownHigh Trading VolumeXBIOXenetic Biosciences1.4302 of 5 stars$4.02+0.8%N/A+34.8%$6.19M$2.54M0.004News CoveragePositive NewsGap DownVCNXVaccinex0.5972 of 5 stars$3.53-4.9%N/A-70.2%$6.11M$570,000.00-0.0740AIMDAinos0.6838 of 5 stars$0.43+1.0%N/A-86.2%$6.01M$120,000.000.0046Gap DownVIRXViracta Therapeutics1.5718 of 5 stars$0.15-1.3%$5.00+3,233.3%-72.4%$5.96MN/A0.0020Analyst RevisionNegative NewsGap Down Related Companies and Tools Related Companies ABVC BioPharma Alternatives Evoke Pharma Alternatives Edesa Biotech Alternatives TransCode Therapeutics Alternatives Adial Pharmaceuticals Alternatives Eyenovia Alternatives Xenetic Biosciences Alternatives Vaccinex Alternatives Ainos Alternatives Viracta Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ALLR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allarity Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allarity Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
